Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
WEHI-345 analog | C23H25N7O | 1354825-62-9 | Details |
WDR5-IN-1 | C30H31FN4O3 | 2408842-51-1 | Details |
WY-135 | C28H34ClN9O3S | 2163060-83-9 | Details |
Mycophenolic acid;RS-61443;Mycophenolate | C17H20O6 | 24280-93-1 | Details |
WS-383 | C18H21Cl2N9S2 | 2247544-02-9 | Details |
Wushanicaritin | C21H22O7 | 521-45-9 | Details |
Wy 49051 | C28H33N5O3 | 113418-56-7 | Details |
Xanomeline oxalate;LY246708 oxalate | C14H23N3OS.C2H2O4 | 141064-23-5 | Details |
Wnt/β-catenin agonist 1 | C22H25N3O2 | 2305372-67-0 | Details |
WS-383 free base | C18H20ClN9S2 | 2247543-65-1 | Details |
WQ 2743 | C19H15BrF3N5O3 | 189280-13-5 | Details |
WQ3810;KPI-10 free base | C22H22F3N5O3 | 888032-58-4 | Details |
Wnt pathway activator 2 | C17H15NO4 | 1360540-82-4 | Details |
20-HEDE;WIT 002 | C20H36O3 | 240427-90-1 | Details |
WDR5-IN-4;WIN site inhibitor 1 | C25H22Cl2FN5O | 2407457-36-5 | Details |
Hydroquinidine;Dihydroquinidine;Hydroconquinine;(+)-Hydroquinidine;Dihydroquinine;Hydroconchinine | C20H26N2O2 | 1435-55-8 | Details |
Win 58237 | C16H17N5O | 158001-76-4 | Details |
Win-62005 | C12H10N4O | 152633-54-0 | Details |
WEHI-539 hydrochloride | C31H30ClN5O3S2 | 2070018-33-4 | Details |
Wf-516 | C25H25Cl2N3O4 | 310392-94-0 | Details |
VTP50469 fumarate | C36H51FN6O8S | 2169919-29-1 | Details |
VTP50469 | C32H47FN6O4S | 2169916-18-9 | Details |
(-)-Enitociclib;(-)-BAY-1251152 | C19H18F2N4O2S | 1610358-59-2 | Details |
(3S,4R)-Tofacitinib | C16H20N6O | 1092578-48-7 | Details |
(3R,4S)-Tofacitinib | C16H20N6O | 1092578-46-5 | Details |
(-)-Talarozole | C21H23N5S | 201410-67-5 | Details |
(1R,2R)-2-PCCA hydrochloride;(1R,2R)-2-PCCA(hydrochloride) | C30H38ClN3O | 1609563-71-4 | Details |
(1R,2S)-VU0155041 | C14H15Cl2NO3 | 1263273-14-8 | Details |
ZYZ-488 | C20H29N3O11 | 1470302-79-4 | Details |
CP-319340(free base) | C27H23F3N4O | 186390-35-2 | Details |
3-Chloropropiophenone | C9H9ClO | 936-59-4 | Details |
ROCK-IN-1 | C20H18FN3O | 934387-35-6 | Details |
Zuclomiphene citrate | C32H36ClNO8 | 7619-53-6 | Details |
ZX-29 | C23H28ClN7O3S | 2254805-62-2 | Details |
Zabofloxacin hydrochloride;DW-224a | C19H21ClFN5O4 | 623574-00-5 | Details |
ZT 52656A hydrochloride | C19H26ClF3N2O | 115730-24-0 | Details |
Zoniporide hydrochloride hydrate;CP-597396 hydrochloride hydrate | C17H19ClN6O2 | 863406-85-3 | Details |
ZM223 | C23H17F3N4O2S2 | 2031177-48-5 | Details |
ZLDI-8 | C24H23N3O3S | 667880-38-8 | Details |
ZLN024 | C13H13BrN2OS | 723249-01-2 | Details |
ZK824859 | C23H22F2N2O4 | 2271122-53-1 | Details |
Nortropine;Nortropenol | C7H13NO | 538-09-0 | Details |
ZK824190 | C22H20F2N2O4 | 2254001-81-3 | Details |
ZK756326 dihydrochloride | C21H29ClN2O3 | 1780259-94-0 | Details |
Zabofloxacin;DW-224a Free base | C19H20FN5O4 | 219680-11-2 | Details |
ZK-90055 hydrochloride | C16H23ClN2O4 | 84638-81-3 | Details |
Fanapanel hydrate;ZK200775 (hydrate);MPQX hydrate | C14H17F3N3O7P | 1255517-78-2 | Details |
ZK168281 | C32H46O5 | 186371-96-0 | Details |
ZK-261991 | C24H25N7O2 | 886563-25-3 | Details |
Ziresovir;AK0529;RO-0529 | C22H25N5O3S | 1422500-60-4 | Details |
ZEN-3219 | C19H18N2O3 | 1952264-34-4 | Details |
Ziprasidone D8;CP-88059 D8 | C21H13ClD8N4OS | 1126745-58-1 | Details |
N-Carbethoxy-4-piperidone | C8H13NO3 | 29976-53-2 | Details |
Zinterol;MJ 9184 | C19H26N2O4S | 37000-20-7 | Details |
Zinc Protoporphyrin;ZnPP;Zn(II)-protoporphyrin IX;Zinc Protoporphyrin-9 | C34H31N4O4Zn- | 15442-64-5 | Details |
ZINC03129319 | C24H14N2O6S2 | 1777807-64-3 | Details |
ZINC13466751 | C20H21N5O2 | 117953-17-0 | Details |
ZEN-3862 | C19H17FN2O3 | 1952264-33-3 | Details |
Zidebactam sodium salt;WCK-5107 sodium salt | C??H??N?NaO?S | 1706777-46-9 | Details |
ZEN-3411 | C21H20N4O2 | 1952264-36-6 | Details |
Zearalanone | C18H24O5 | 5975-78-0 | Details |
ZD-0892 | C24H32F3N3O5 | 171964-73-1 | Details |
ZD 7155(hydrochloride) | C26H27ClN6O | 146709-78-6 | Details |
5-Azacytidine;5-AzaC;NSC 102816;Ladakamycin;Mylosar;Azacitidine | C8H12N4O5 | 320-67-2 | Details |
Zaurategrast ethyl ester sulfate;CDP323 sulfate;UCB1184197 sulfate | C56H60Br2N8O10S | 1214261-78-5 | Details |
Zatebradine;UL-FS-49CL free base;UL-FS-49 free base | C26H36N2O5 | 85175-67-3 | Details |
Zandelisib | C31H38F2N8O | 1401436-95-0 | Details |
Zamifenacin fumarate;UK-76654 fumarate | C31H33NO7 | 127308-98-9 | Details |
Y-33075;Y 39983 | C16H16N4O | 199433-58-4 | Details |
Y-33075 dihydrochloride | C16H18Cl2N4O | 173897-44-4 | Details |
Zamicastat;BIA 5-1058 | C21H21F2N3OS | 1080028-80-3 | Details |
(Z)-Pitavastatin calcium | C25H26CaFNO4 | 1159588-21-2 | Details |
Sucralfate;Sucrose octasulfate–aluminum complex | C11H52Al16O75S8-16 | 54182-58-0 | Details |
Z433927330 | C20H20N4O3 | 1005883-72-6 | Details |
(Z)-10-Hydroxynortriptyline;(Z)-10-Hydroxy Nortriptyline | C19H21NO | 47132-19-4 | Details |
Zaltidine;CP-57361 | C8H10N6S | 85604-00-8 | Details |
(Z)-Leukadherin-1;ADH-503 free base | C22H15NO4S2 | 2055362-72-4 | Details |
Z-Asp-CH2-DCB | C20H17Cl2NO7 | 153088-73-4 | Details |
YS-49 | C20H20BrNO2 | 132836-42-1 | Details |
YM758 | C26H32FN3O4 | 312752-85-5 | Details |
YM17E | C40H56N6O2 | 124900-72-7 | Details |
YM-46303 | C20H23ClN2O2 | 171722-81-9 | Details |
YM-58790 | C27H32ClN3O2 | 214558-72-2 | Details |
YM-53601 free base | C21H21FN2O | 182959-28-0 | Details |
Pamidronate Disodium;CGP 23339AE;CGP 23339A;Pamidronate disodium salt | C3H12NNaO7P2 | 57248-88-1 | Details |
YM-264 | C24H32N4OS.C4H4O4 | 131888-54-5 | Details |
YLF-466D;C24 | C29H20ClNO3 | 1273323-67-3 | Details |
YHO-13351 | C27H37N3O7S2 | 1346753-00-1 | Details |
YHO-13351 free base | C26H33N3O4S | 912288-64-3 | Details |
YAP/TAZ inhibitor-1 | C33H39N3O5S2 | 2093565-23-0 | Details |
Y06137 | C27H32N4O2 | 2226534-49-0 | Details |
XY101 | C25H20F7NO4S | 2349368-16-5 | Details |
XL-784 | C21H22ClF2N3O8S | 1224964-36-6 | Details |
XY028-133 | C53H67N11O7S | 2229974-73-4 | Details |
Benztropine mesylate;Benzatropine mesylate;Benztropine methanesulfonate;Benzotropine mesylate | C22H29NO4S | 132-17-2 | Details |
XPC-6444 | C22H25F3N4O2S2 | 2230144-21-3 | Details |
XL-784 free base | C21H22ClF2N3O8S | 1356992-21-6 | Details |
XEN723 | C21H20FN5O2S | 1072803-08-7 | Details |
Xanthoangelol | C25H28O4 | 62949-76-2 | Details |
Xanthorrhizol | C15H22O | 30199-26-9 | Details |
Product Total: Product Page: | ||||
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 |